Frequency of genomic biomarkers of response to immunotherapy in sarcoma.

11579Background: Recent data (D’Angelo et al, 2018) has suggested possible benefit for a subset of sarcoma patients from immune checkpoint inhibitors (ICPI). We assessed a large sarcoma population ...